Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4F16 Inhibitors

Chemical inhibitors of Olfactory receptor 4F3/4F16/4F29 include a variety of compounds that inhibit the activity of this protein. Cycloheximide, for instance, targets the very foundation of protein function by inhibiting eukaryotic protein synthesis, thereby preventing the translation and proper folding of Olfactory receptor 4F3/4F16/4F29 into its active conformation. Similarly, compounds like Quinidine and Lidocaine exert their inhibitory effects by blocking voltage-gated sodium channels, which are crucial for the excitability of olfactory sensory neurons. This reduction in neuronal excitability diminishes the receptor's ability to transmit signals, effectively inhibiting its function. 1-Hydroxypyridine-2-thione zinc salt takes a different approach by binding to metal ion sites on the receptor, altering its structure and reducing sensitivity to odorant molecules, while Tetrodotoxin specifically targets sodium channels to inhibit action potential propagation in olfactory neurons. Furthermore, Capsazepine and Ruthenium Red modulate intracellular calcium levels, which are essential for signal transduction processes involving Olfactory receptor 4F3/4F16/4F29. By antagonizing TRPV1 receptors and inhibiting calcium channels respectively, these chemicals decrease the intracellular calcium concentration, crucial for the receptor's signaling pathway. Amiloride, by inhibiting both sodium channels and epithelial sodium channels, alters ion homeostasis and membrane potential, which are vital for receptor activation and subsequent signal transduction. On the neurotransmitter level, chemicals like Bicuculline and Dihydro-β-erythroidine disrupt normal neurotransmitter release and neuronal excitability in olfactory pathways by antagonizing GABA_A receptors and nicotinic acetylcholine receptors, respectively. This dysregulation of neurotransmitter systems can inhibit the proper functioning of Olfactory receptor 4F3/4F16/4F29. Lastly, α-Bungarotoxin, by inhibiting nicotinic acetylcholine receptors, disrupts acetylcholine signaling pathways, further inhibiting the receptor's ability to participate in olfactory signal transduction. Through these various mechanisms, each chemical contributes to the functional inhibition of Olfactory receptor 4F3/4F16/4F29, impacting its role in olfactory signaling without the need to decrease its expression directly.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis in eukaryotic organisms, which can indirectly inhibit Olfactory receptor 4F3/4F16/4F29 function by preventing its translation and subsequent folding into an active conformation.

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

Quinidine, as a blocker of voltage-gated sodium channels, may inhibit Olfactory receptor 4F3/4F16/4F29 by reducing the excitability of olfactory sensory neurons, thereby diminishing the receptor's signaling capacity.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

1-Hydroxypyridine-2-thione zinc salt can inhibit Olfactory receptor 4F3/4F16/4F29 by binding to the receptor's metal ion sites, altering its conformation and decreasing its sensitivity to odorant molecules.

Capsazepine

138977-28-3sc-201098
sc-201098A
5 mg
25 mg
$148.00
$459.00
11
(1)

Capsazepine, a TRPV1 antagonist, may inhibit Olfactory receptor 4F3/4F16/4F29 by modulating the intracellular calcium levels, which are crucial for the receptor's signal transduction process.

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

Ruthenium Red inhibits calcium channels, which could lead to inhibition of Olfactory receptor 4F3/4F16/4F29 by decreasing intracellular calcium, a key secondary messenger in olfactory signal transduction.

Lidocaine

137-58-6sc-204056
sc-204056A
50 mg
1 g
$51.00
$131.00
(0)

Lidocaine, as a local anesthetic, inhibits voltage-gated sodium channels, which could inhibit Olfactory receptor 4F3/4F16/4F29 by preventing action potential generation and propagation in olfactory neurons.

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Amiloride inhibits sodium channels and epithelial sodium channels, which could inhibit Olfactory receptor 4F3/4F16/4F29 by altering ion homeostasis and membrane potential, affecting receptor activation and signal transduction.

(+)-Bicuculline

485-49-4sc-202498
sc-202498A
50 mg
250 mg
$82.00
$281.00
(1)

Bicuculline, a GABA_A receptor antagonist, may inhibit Olfactory receptor 4F3/4F16/4F29 by increasing neuronal excitability and thereby dysregulating the olfactory signaling pathways that depend on GABAergic inhibition for proper function.

α-Bungarotoxin

11032-79-4sc-202897
1 mg
$351.00
5
(1)

α-Bungarotoxin, by inhibiting nicotinic acetylcholine receptors, may inhibit Olfactory receptor 4F3/4F16/4F29 by disrupting acetylcholine signaling, affecting olfactory neuron activation and signal transduction.